Publication | Closed Access

Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response

Breast OncologyImmunologyBreast CancerBetter PrognosisTumor SuppressorMedicineCell BiologyCell SignalingCancer Research